BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 15610858)

  • 1. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
    Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
    Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in early-stage bilharzial bladder cancer.
    Aly MS; Khaled HM
    Cancer Genet Cytogenet; 2002 Jan; 132(1):41-5. PubMed ID: 11801307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of C-erb B2 gene amplification in bilharzial associated bladder cancer using fluorescence in situ hybridization.
    Aly MS; Khaled HM
    Urol Oncol; 2004; 22(6):448-52. PubMed ID: 15610859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
    Muscheck M; Abol-Enein H; Chew K; Moore D; Bhargava V; Ghoneim MA; Carroll PR; Waldman FM
    Carcinogenesis; 2000 Sep; 21(9):1721-6. PubMed ID: 10964104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic profile of locally advanced and metastatic Schistosoma-related bladder cancer and response to chemotherapy.
    Aly MS; Khaled HM; Emara M; Hussein TD
    Cancer Genet; 2012 Apr; 205(4):156-62. PubMed ID: 22559976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
    Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
    J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
    Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
    Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
    Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
    J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
    Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
    Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
    Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
    Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
    Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.